<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="314">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 24, 2013</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01372774</url>
  </required_header>
  <id_info>
    <org_study_id>N107C</org_study_id>
    <secondary_id>NCCTG-N107C</secondary_id>
    <secondary_id>CDR0000701474</secondary_id>
    <secondary_id>NCI-2011-02676</secondary_id>
    <nct_id>NCT01372774</nct_id>
  </id_info>
  <brief_title>Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery</brief_title>
  <official_title>A Phase III Trial of Post-Surgical Stereotactic Radiosurgery (SRS) Compared With Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>North Central Cancer Treatment Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Alliance for Clinical Trials in Oncology</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Stereotactic radiosurgery may be able to send x-rays directly to the tumor and
      cause less damage to normal tissue. Radiation therapy uses high-energy x rays to kill tumor
      cells. It is not yet known whether stereotactic radiosurgery is more effective than
      whole-brain radiation therapy in treating patients with brain metastases that have been
      removed by surgery.

      PURPOSE: This randomized phase III trial studies how well stereotactic radiosurgery works
      compared to whole-brain radiation therapy in treating patients with brain metastases that
      have been removed by surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

      Primary

        -  To ascertain in patients with one to four brain metastases whether there is improved
           overall survival in patients who receive stereotactic radiosurgery (SRS) to the
           surgical bed compared to patients who receive whole-brain radiotherapy (WBRT).

        -  To ascertain in patients with one to four brain metastases whether there is less
           neurocognitive progression at 6 months post-radiation in patients who receive SRS to
           the surgical bed compared to patients who receive WBRT.

      Secondary

        -  To ascertain in patients with resected brain metastases whether there is improved
           quality-of-life (QOL) in patients who receive SRS to the surgical bed compared to
           patients who receive WBRT.

        -  To ascertain in patients with one to four brain metastases whether there is equal
           longer time to central nervous system (CNS) failure (brain) in patients who receive SRS
           to the surgical bed compared to patients who receive WBRT.

        -  To ascertain in patients with one to four brain metastases whether there is longer
           duration of functional independence in patients who receive SRS to the surgical bed
           compared to patients who receive WBRT.

        -  To ascertain in patients with one to four brain metastases whether there is better
           long-term neurocognitive status in patients who receive SRS to the surgical bed
           compared to patients who receive WBRT.

        -  To tabulate and descriptively compare the post-treatment adverse events associated with
           the interventions.

        -  To evaluate local tumor bed recurrence at 6 months with post-surgical SRS to the
           surgical bed in comparison to WBRT.

        -  To evaluate time to local recurrence with post-surgical SRS to the surgical bed in
           comparison to WBRT.

        -  To evaluate if there is any difference in CNS failure patterns (local, distant,
           leptomeningeal) in patients who receive SRS to the surgical bed compared to patients
           who receive WBRT.

      Exploratory

        -  To evaluate radiation changes in the limbic system that may correlate with
           neurotoxicity using brain MRI scans.

        -  To determine whether Apo E (i.e., Apo E2, Apo E3, and Apo E4) genotyping may prove to
           be a predictor of radiation-induced neurocognitive decline (or neuroprotection).

        -  To determine whether inflammatory markers (i.e., IL-1, IL-6, and TNF-α) may prove to be
           predictors of radiation-induced neurocognitive decline.

        -  To determine whether oxidative stress biomarkers (i.e., protein carbonyl content, lipid
           hydroperoxides, and isoprostane levels) may prove to be predictors of radiation-induced
           neurocognitive decline.

        -  To determine whether hormone and growth factors [i.e., glucocorticoids (e.g.,
           cortisol), gonadal steroids (e.g., estradiol, testosterone, progesterone), growth
           hormone, human chorionic gonadotropin (hCG), insulin-like growth factor-1 (IGF-1), and
           neuronal growth factor (NGF)] may prove to be a predictor of radiation-induced
           neurocognitive decline.

      OUTLINE: This is a multicenter study. Patients are stratified according to age in years (&lt;
      60 vs ≥ 60), extracranial disease controlled (≤ 3 months vs &gt; 3 months), number of
      pre-operative brain metastases (1 vs 2-4), histology (lung vs radioresistant [brain
      metastases from a sarcoma, melanoma, or renal cell carcinoma histology] vs other), and
      resection cavity maximal diameter (≤ 3 cm vs &gt; 3 cm). Patients are randomized to 1 of 2
      treatment arms.

        -  Arm I: Patients undergo whole-brain radiotherapy (WBRT) once a day, 5 days a week, for
           approximately 3 weeks.

        -  Arm II: Patients undergo stereotactic radiosurgery (SRS) using a gamma knife or a
           linear accelerator procedure.

      Serum, whole blood, and urine samples are collected at baseline and periodically during
      study for genetic markers, inflammatory markers, oxidative stress biomarkers, and hormone
      and growth factor studies by ELISA and other assays.

      Patients complete the Functional Assessment of Cancer Therapy-Brain (FACT-BR), the
      activities of daily living (ADLs), the Fatigue/Uniscale Assessment, and the Linear Analog
      Self Assessment (LASA) quality-of-life questionnaires at baseline and periodically during
      study. Neurocognitive functions, such as memory, verbal fluency, visual attention, executive
      function, and delayed memory, are also assessed.

      After completion of study therapy, patients are followed up periodically for 5 years.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2011</start_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Neurocognitive progression at 6 months post-radiation in patients who received SRS compared to patients who received WBRT</measure>
    <time_frame>Up to 6 months post radiation</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>Up to 6 months post radiation</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Local control of the surgical bed</measure>
    <time_frame>Up to 6 months post radiation</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to CNS failure in these patients</measure>
    <time_frame>Up to 6 months post radiation</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality-of-life at 6 months of these patients</measure>
    <time_frame>Up to 6 months post randomization</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">192</enrollment>
  <condition>Cognitive/Functional Effects</condition>
  <condition>Metastatic Cancer</condition>
  <condition>Neurotoxicity</condition>
  <condition>Radiation Toxicity</condition>
  <condition>Unspecified Adult Solid Tumor, Protocol Specific</condition>
  <arm_group>
    <arm_group_label>Arm I</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients undergo whole brain radiotherapy (WBRT) once a day, 5 days a week, for approximately 3 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm II</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo stereotactic radiosurgery (SRS) using a gamma knife or a linear accelerator procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>stereotactic radiosurgery</intervention_name>
    <description>Undergo RT</description>
    <arm_group_label>Arm II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>whole-brain radiation therapy</intervention_name>
    <description>Undergo radiotherapy (RT)</description>
    <arm_group_label>Arm I</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Four or fewer brain metastases (as defined on the pre-operative MRI brain scan) and
             status post resection of one of the lesions

          -  Pathology from the resected brain metastasis must be consistent with a non-central
             nervous system primary site

               -  Patients with or without active disease outside the nervous system are eligible
                  (including patients with unknown primaries), as long as the pathology from the
                  brain is consistent with a non-central nervous system primary site

          -  Any unresected lesions must measure ≤ 3.0 cm in maximal extent on the contrasted MRI
             brain scan obtained ≤ 35 days prior to pre-registration

               -  The metastases size restriction does not apply to the resected brain metastasis;
                  with resected brain metastases only surgical cavity size determines eligibility

          -  Post-operative MRI confirmed zero, one, two or three unresected lesions

               -  Each unresected lesion must measure ≤ 3.0 cm in maximal extent on the contrasted
                  post-operative MRI brain scan

               -  The pre-registration, post-operative, brain scan may be used for the
                  randomization scan if obtained ≤ 28 days prior to randomization

                    -  Note: If there are no unresected brain metastases (i.e., all brain
                       metastases have been resected), a post-operative CT brain scan may be used
                       if obtained ≤ 28 days prior to randomization

          -  Resection cavity must measure &lt; 5.0 cm in maximal extent on the post-operative MRI
             (or CT) brain scan obtained ≤ 35 days prior to pre-registration

               -  The pre-registration, post-operative brain scan may be used for the planning
                  scan if obtained ≤ 28 days prior to randomization

                    -  Note: If there are no unresected brain metastases (i.e., all brain
                       metastases have been resected), a post-operative CT brain scan may be used
                       if obtained ≤ 28 days prior to randomization

               -  It is permissible for the resection of a dominant brain metastasis to include a
                  smaller &quot;satellite&quot; metastasis as long as the single resection cavity is less
                  than the maximum size requirements

          -  All standard tumor-staging procedures necessary to define baseline extracranial
             disease status completed ≤ 42 days prior to pre-registration

          -  No primary germ cell tumor, small cell carcinoma, or lymphoma

          -  No widespread definitive leptomeningeal metastasis

          -  No brain metastasis that is located ≤ 5 mm of the optic chiasm or within the
             brainstem

        PATIENT CHARACTERISTICS:

          -  ECOG performance status (PS) 0, 1, or 2

          -  Ability to be treated with either a gamma knife or a linear accelerator-based
             radiosurgery system

          -  Willing and able to complete neurocognitive examination without assistance

          -  Willing and able to complete quality-of-life (QOL) questionnaires by themselves or
             with assistance

          -  Willing to provide mandatory blood and urine samples for correlative research
             purposes

          -  None of the following:

               -  Pregnant or nursing

               -  Men or women of childbearing potential who are unwilling to employ adequate
                  contraception through out the study and for men for up to 3 months after
                  completing treatment

          -  Able to complete a MRI with contrast of the head

          -  No known allergy to gadolinium

        PRIOR CONCURRENT THERAPY:

          -  No prior cranial radiotherapy

          -  No planned cytotoxic chemotherapy during the stereotactic radiosurgery (SRS) or
             whole-brain radiotherapy (WBRT)

          -  Concurrent hormonal agents, steroids, and/or anticonvulsants allowed
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul D. Brown, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadia Laack, M.D.</last_name>
      <phone>507-284-4561</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mills - Peninsula Hospitals</name>
      <address>
        <city>Burlingame</city>
        <state>California</state>
        <zip>94010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ari Baron, M.D.</last_name>
      <phone>415-923-3012</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Chang, M.D.</last_name>
      <phone>323-865-3072</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Los Angeles County-USC Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Chang, M.D.</last_name>
      <phone>323-865-3072</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>USC/Norris Comprehensive Cancer Center and Hospital</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90089-9181</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - USC/Norris Comprehensive Cancer Cente</last_name>
      <phone>323-865-0451</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Medical Center</name>
      <address>
        <city>Modesto</city>
        <state>California</state>
        <zip>95355</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jorge Garcia-Young, M.D.</last_name>
      <phone>209-572-7237</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente-South San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94080</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samantha Seaward, M.D.</last_name>
      <phone>408-851-8000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo R. Pajon, MD</last_name>
      <phone>303-399-8020</phone>
      <phone_ext>2261</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Mary - Corwin Regional Medical Center</name>
      <address>
        <city>Pueblo</city>
        <state>Colorado</state>
        <zip>81004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo R. Pajon, MD</last_name>
      <phone>303-399-8020</phone>
      <phone_ext>2261</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>CCOP - Christiana Care Health Services</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trial Office - CCOP - Christiana Care Health Services</last_name>
      <phone>302-623-4450</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Broward Health North</name>
      <address>
        <city>Deerfield Beach</city>
        <state>Florida</state>
        <zip>33064</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marshal Lieberfarb</last_name>
      <phone>954-786-6747</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic in Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadia Laack, M.D.</last_name>
      <phone>507-284-4561</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CCOP - Mount Sinai Medical Center</name>
      <address>
        <city>Miami Beach</city>
        <state>Florida</state>
        <zip>33140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie E. Blach</last_name>
      <phone>305-674-2625</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>M.D. Anderson Cancer Center at Orlando</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naren R. Ramakrishna</last_name>
      <phone>407-648-3800</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>John B Amos Cancer Center</name>
      <address>
        <city>Columbus</city>
        <state>Georgia</state>
        <zip>31904</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Douglas Ciuba, M.D.</last_name>
      <phone>706-571-1050</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Evanston CCOP-NorthShore University HealthSystem</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ryan Merrell, M.D.</last_name>
      <phone>847-570-2570</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Advocate Christ Medical Center</name>
      <address>
        <city>Oak Lawn</city>
        <state>Illinois</state>
        <zip>60453-2699</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Faisal S. Vali</last_name>
      <phone>708-684-8000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Hospital of South Bend</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Memorial Hospital of South Bend</last_name>
      <phone>800-284-7370</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mercy Regional Cancer Center at Mercy Medical Center</name>
      <address>
        <city>Cedar Rapids</city>
        <state>Iowa</state>
        <zip>52403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah W. Wilbur</last_name>
      <phone>319-398-6011</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Louisville Oncology at Norton Cancer Institute - Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Louisville Oncology</last_name>
      <phone>502-629-2500</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>MedStar Franklin Square Medical Center/Weinberg Cancer Institute</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21237</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Perry, M.D.</last_name>
      <phone>410-682-6800</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center Cancer Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lynne P. Taylor</last_name>
      <phone>617-636-6100</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lowell General Hospital</name>
      <address>
        <city>Lowell</city>
        <state>Massachusetts</state>
        <zip>01854</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Katz, M.D.</last_name>
      <phone>978-937-6650</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Vincent Hospital/Reliant Medical Group</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Casey, M.D.</last_name>
      <phone>508-363-7100</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wayne State University</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harold Kim, M.D.</last_name>
      <phone>313-966-0556</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>West Michigan Cancer Center</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49007-3731</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - West Michigan Cancer Center</last_name>
      <phone>269-373-7458</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sanford Clinic North-Bemidji</name>
      <address>
        <city>Bemidji</city>
        <state>Minnesota</state>
        <zip>56601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Preston Steen, M.D.</last_name>
      <phone>701-234-6161</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Cancer Center</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - All Mayo Clinic Locations</last_name>
      <phone>507-538-7623</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CentraCare Clinic - River Campus</name>
      <address>
        <city>Saint Cloud</city>
        <state>Minnesota</state>
        <zip>56303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donald J. Jurgens</last_name>
      <phone>320-252-5131</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Regions Hospital</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Flynn, M.D.</last_name>
      <phone>952-993-1517</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>United Hospital</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick J. Flynn, MD</last_name>
      <phone>612-884-6300</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cape Radiation Oncology</name>
      <address>
        <city>Cape Girardeau</city>
        <state>Missouri</state>
        <zip>63703</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tapan Roy</last_name>
      <phone>573-334-2230</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Institute of Cape Girardeau, LLC</name>
      <address>
        <city>Cape Girardeau</city>
        <state>Missouri</state>
        <zip>63703</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tapan Roy, MD</last_name>
      <phone>573-334-2230</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Billings Clinic - Downtown</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59107-7000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Billings Clinic - Downtown</last_name>
      <phone>800-996-2663</phone>
      <email>research@billingsclinic.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Wahl, M.D.</last_name>
      <phone>402-552-3844</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seacoast Cancer Center at Wentworth - Douglass Hospital</name>
      <address>
        <city>Dover</city>
        <state>New Hampshire</state>
        <zip>03820</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arul Mahadevan</last_name>
      <phone>603-742-8787</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Exeter Hospital</name>
      <address>
        <city>Exeter</city>
        <state>New Hampshire</state>
        <zip>03833</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gary Proulx, M.D.</last_name>
      <phone>603-580-7337</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Somerset Medical Center</name>
      <address>
        <city>Somerville</city>
        <state>New Jersey</state>
        <zip>08876</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Chimenti, M.D.</last_name>
      <phone>732-302-1720</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>SUNY Upstate Medical University Hospital</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - SUNY Upstate Medical University Hospi</last_name>
      <phone>315-464-5476</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599-7295</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Lineberger Comprehensive Cancer Cente</last_name>
      <phone>877-668-0683</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Presbyterian Cancer Center at Presbyterian Hospital</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28233-3549</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Presbyterian Cancer Center at Presbyt</last_name>
      <phone>704-384-5369</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Comprehensive Cancer Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157-1096</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Wake Forest University  Comprehensive</last_name>
      <phone>336-713-6771</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medcenter One Hospital Cancer Care Center</name>
      <address>
        <city>Bismarck</city>
        <state>North Dakota</state>
        <zip>58501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John T. Reynolds</last_name>
      <phone>701-323-5741</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mid Dakota Clinic, PC</name>
      <address>
        <city>Bismarck</city>
        <state>North Dakota</state>
        <zip>58501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Mid Dakota Clinic, PC</last_name>
      <phone>701-530-6950</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sanford Bismarck Medical Center</name>
      <address>
        <city>Bismarck</city>
        <state>North Dakota</state>
        <zip>58501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Preston Steen, M.D.</last_name>
      <phone>701-234-6161</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sanford Clinic North-Fargo</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Preston Steen, M.D.</last_name>
      <phone>701-234-6161</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sanford Roger Maris Cancer Center</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Preston Steen, M.D.</last_name>
      <phone>701-234-6161</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Summa Center for Cancer Care at Akron City Hospital</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44309-2090</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Akron City Hospital</last_name>
      <phone>330-375-6101</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Case Comprehensive Cancer Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106-5065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Case Comprehensive Cancer Center</last_name>
      <phone>800-641-2422</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Taussig Cancer Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Cleveland Clinic Taussig Cancer Cente</last_name>
      <phone>866-223-8100</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mount Carmel St. Ann's Cancer Center</name>
      <address>
        <city>Westerville</city>
        <state>Ohio</state>
        <zip>43081</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J. Philip Kuebler, MD, PhD</last_name>
      <phone>614-442-3130</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Natalie Warren Bryant Cancer Center at St. Francis Hospital</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles E. Stewart</last_name>
      <phone>918-494-2273</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Natalie W Bryant Cancer Center</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Stewart, M.D.</last_name>
      <phone>918-494-1585</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Legacy Good Samaritan Hospital &amp; Comprehensive Cancer Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Legacy Good Samaritan Hospital &amp;  Com</last_name>
      <phone>503-413-1742</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Salem Hospital Regional Cancer Care Services</name>
      <address>
        <city>Salem</city>
        <state>Oregon</state>
        <zip>97309-5014</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Salem Hospital Regional Cancer Care S</last_name>
      <phone>503-561-2618</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rosenfeld Cancer Center at Abington Memorial Hospital</name>
      <address>
        <city>Abington</city>
        <state>Pennsylvania</state>
        <zip>19001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Rosenfeld Cancer Center at Abington M</last_name>
      <phone>215-481-2402</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suresh G. Nair, MD</last_name>
      <phone>610-402-0512</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Luke's University Hospital-Bethlehem Campus</name>
      <address>
        <city>Bethlehem</city>
        <state>Pennsylvania</state>
        <zip>18015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deb Nimisha, M.D.</last_name>
      <phone>484-503-4400</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Geisinger Cancer Institute at Geisinger Health</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822-0001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Geisinger Cancer Institute</last_name>
      <phone>570-271-5251</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Frankford Hospital Cancer Center - Torresdale Campus</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Avnish Bhatia</last_name>
      <phone>215-612-4880</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aria Health-Torresdale Campus</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Voichita Bar Ad, M.D.</last_name>
      <phone>215-955-0284</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hollings Cancer Center at Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Hollings Cancer Center at Medical Uni</last_name>
      <phone>843-792-9321</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rapid City Regional Hospital</name>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <zip>57701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard C. Tenglin</last_name>
      <phone>605-719-2360</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sanford Cancer Center Oncology Clinic</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miroslaw Mazurczak, M.D.</last_name>
      <phone>605-328-8000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sanford USD Medical Center - Sioux Falls</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57117</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miroslaw Mazurczak, M.D.</last_name>
      <phone>605-328-8000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Thompson Cancer Survival Center</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37916</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Thompson Cancer Survival Center</last_name>
      <phone>865-541-1812</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas Medical Branch</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Todd Swanson, M.D.</last_name>
      <phone>409-772-7186</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dixie Medical Center Regional Cancer Center</name>
      <address>
        <city>Saint George</city>
        <state>Utah</state>
        <zip>84770</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Lee</last_name>
      <phone>713-792-7218</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Huntsman Cancer Institute at University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Huntsman Cancer Institute at Universi</last_name>
      <phone>801-581-4477</phone>
      <email>clinical.trials@hci.utah.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Vincent Hospital Regional Cancer Center</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <zip>54307-3508</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - St. Vincent Hospital Regional Cancer</last_name>
      <phone>920-433-8889</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Joseph's Hospital</name>
      <address>
        <city>Marshfield</city>
        <state>Wisconsin</state>
        <zip>54449</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin E. Lawler</last_name>
      <phone>715-389-3133</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Marshfield Clinic - Marshfield Center</name>
      <address>
        <city>Marshfield</city>
        <state>Wisconsin</state>
        <zip>54449</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Marshfield Clinic - Marshfield Center</last_name>
      <phone>800-782-1581</phone>
      <phone_ext>94457</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>Community Memorial Hospital</name>
      <address>
        <city>Menomonee Falls</city>
        <state>Wisconsin</state>
        <zip>53051</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Bovi, M.D.</last_name>
      <phone>414-805-4474</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vince Lombardi Cancer Clinic at Aurora St. Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Vince Lombardi Cancer Clinic</last_name>
      <phone>414-649-5717</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Froedtert and the Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Bovi, M.D.</last_name>
      <phone>414-805-4474</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nova Scotia Cancer Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 1V8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liam A. Mulroy</last_name>
      <phone>902-473-6000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Margaret and Charles Juravinski Cancer Centre</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8V 5C2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anthony C. Whitton</last_name>
      <phone>905-387-9495</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Princess Margaret Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Normand J. Laperriere</last_name>
      <phone>416-946-2811</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Notre-Dame du CHUM</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2L 4M1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Roberge</last_name>
      <phone>514-281-6000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Quebec</name>
      <address>
        <city>Quebec City</city>
        <state>Quebec</state>
        <zip>G1R 2J6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanie Gaudreault</last_name>
      <phone>418-525-4444</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHUS-Hopital Fleurimont</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H 5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence Masson-Cote</last_name>
      <phone>819-346-1110</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://cancer.gov/clinicaltrials/NCCTG-N107C</url>
    <description>Clinical trial summary from the National Cancer Institute's PDQ® database</description>
  </link>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 22, 2013</lastchanged_date>
  <firstreceived_date>June 11, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>neurotoxicity</keyword>
  <keyword>radiation toxicity</keyword>
  <keyword>cognitive/functional effects</keyword>
  <keyword>tumors metastatic to brain</keyword>
  <keyword>unspecified adult solid tumor, protocol specific</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Neoplasms, Second Primary</mesh_term>
    <mesh_term>Neurotoxicity Syndromes</mesh_term>
    <mesh_term>Radiation Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
